Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition
TW202100159A
Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a complication risk factor
TW202039575A
Novel anti-ccr8 antibody
TW202003517A
Polycyclic pyridotriazine derivative
AU2019258575A1
Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity
TW201930314A
Tricyclic compounds having sulfinyl and pharmaceutical compositions containing them
TW201922259A
Pharmaceutical preparation excellent in light stability and dissolution property
TW201908313A
Condensation ring derivative having MGAT2 inhibitory activity
TW201932461A
Nitrogen-containing fused ring compounds having dopamine D3 receptor antagonistic activity
TW201821411A
Nitrogen containing 6-membered heterocyclyc derivatives and pharmaceutical composition comprising the same
TW201808282A
Pharmaceutical composition for inhalation
TW201613982A
Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
TW201529567A
Aminotriazine derivative and pharmaceutical composition comprising the same
AU2014230640A1
Monoclonal antibody inhibiting enzymatic activity of endothelial lipase
AU2012211458A1
Amine derivative having NPY Y5 receptor antagonist activity
AU2009203426A1
Antibody directed against PcrV
AU2006328412A1
Prognostic prediction method for acute coronary syndrome
AU2006316087A1
Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I
